nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP3A4—Thiotepa—urinary bladder cancer	0.09	0.253	CbGbCtD
Fenofibrate—CYP2C8—Fluorouracil—urinary bladder cancer	0.0721	0.202	CbGbCtD
Fenofibrate—CYP2C8—Etoposide—urinary bladder cancer	0.0602	0.169	CbGbCtD
Fenofibrate—CYP2C9—Fluorouracil—urinary bladder cancer	0.0503	0.141	CbGbCtD
Fenofibrate—CYP2C9—Cisplatin—urinary bladder cancer	0.0427	0.12	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—urinary bladder cancer	0.0244	0.0685	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—urinary bladder cancer	0.0166	0.0467	CbGbCtD
Fenofibrate—PPARA—prostate gland—urinary bladder cancer	0.00793	0.15	CbGeAlD
Fenofibrate—CYP2C9—urine—urinary bladder cancer	0.00711	0.134	CbGeAlD
Fenofibrate—PPARA—epithelium—urinary bladder cancer	0.00583	0.11	CbGeAlD
Fenofibrate—PPARA—smooth muscle tissue—urinary bladder cancer	0.00561	0.106	CbGeAlD
Fenofibrate—CYP3A4—urine—urinary bladder cancer	0.00542	0.103	CbGeAlD
Fenofibrate—PPARA—renal system—urinary bladder cancer	0.0054	0.102	CbGeAlD
Fenofibrate—Indomethacin—UGT2B7—urinary bladder cancer	0.00457	0.378	CrCbGaD
Fenofibrate—PPARA—female reproductive system—urinary bladder cancer	0.00433	0.0818	CbGeAlD
Fenofibrate—Indomethacin—CXCL8—urinary bladder cancer	0.00258	0.213	CrCbGaD
Fenofibrate—PPARA—lymph node—urinary bladder cancer	0.00253	0.0479	CbGeAlD
Fenofibrate—Bezafibrate—PPARG—urinary bladder cancer	0.00241	0.199	CrCbGaD
Fenofibrate—CYP2C8—renal system—urinary bladder cancer	0.00196	0.037	CbGeAlD
Fenofibrate—Indomethacin—PPARG—urinary bladder cancer	0.00178	0.147	CrCbGaD
Fenofibrate—CYP2C8—female reproductive system—urinary bladder cancer	0.00157	0.0297	CbGeAlD
Fenofibrate—CYP2C8—vagina—urinary bladder cancer	0.00142	0.0268	CbGeAlD
Fenofibrate—CYP2C9—female reproductive system—urinary bladder cancer	0.00139	0.0263	CbGeAlD
Fenofibrate—CYP3A4—renal system—urinary bladder cancer	0.00133	0.0251	CbGeAlD
Fenofibrate—CYP3A4—female reproductive system—urinary bladder cancer	0.00106	0.0201	CbGeAlD
Fenofibrate—Indomethacin—PTGS2—urinary bladder cancer	0.000753	0.0623	CrCbGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000678	0.00422	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00067	0.00417	CbGpPWpGaD
Fenofibrate—PPARA—Circadian Clock—EP300—urinary bladder cancer	0.00067	0.00416	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CNTN2—urinary bladder cancer	0.000659	0.0041	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000658	0.0041	CbGpPWpGaD
Fenofibrate—PPARA—Organelle biogenesis and maintenance—NCOR1—urinary bladder cancer	0.000658	0.00409	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—FAS—urinary bladder cancer	0.000643	0.004	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—UGT2B7—urinary bladder cancer	0.000629	0.00391	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00062	0.00386	CbGpPWpGaD
Fenofibrate—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000607	0.00378	CbGpPWpGaD
Fenofibrate—PPARA—Orphan transporters—CREBBP—urinary bladder cancer	0.000591	0.00367	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTZ1—urinary bladder cancer	0.00059	0.00367	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000588	0.00366	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000582	0.00362	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000575	0.00358	CbGpPWpGaD
Fenofibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000572	0.00356	CbGpPWpGaD
Fenofibrate—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.00057	0.00354	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—CYP4B1—urinary bladder cancer	0.000566	0.00352	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000565	0.00351	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00056	0.00348	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000559	0.00348	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000559	0.00348	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000558	0.00347	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000553	0.00344	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000553	0.00344	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000552	0.00343	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—PPARG—urinary bladder cancer	0.000514	0.0032	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000512	0.00319	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000512	0.00318	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.000512	0.00318	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000506	0.00315	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000505	0.00314	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—RB1—urinary bladder cancer	0.000492	0.00306	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—IGF1—urinary bladder cancer	0.000488	0.00303	CbGpPWpGaD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000479	0.00298	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000461	0.00287	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000456	0.00284	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000454	0.00283	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—FAS—urinary bladder cancer	0.000454	0.00282	CbGpPWpGaD
Fenofibrate—PPARA—Organelle biogenesis and maintenance—CREBBP—urinary bladder cancer	0.000453	0.00282	CbGpPWpGaD
Fenofibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.000415	0.00258	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000399	0.00248	CbGpPWpGaD
Fenofibrate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000397	0.00247	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000396	0.00247	CbGpPWpGaD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00039	0.00242	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000389	0.00242	CbGpPWpGaD
Fenofibrate—PPARA—PPARA activates gene expression—EP300—urinary bladder cancer	0.000385	0.00239	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000384	0.00239	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTZ1—urinary bladder cancer	0.000382	0.00238	CbGpPWpGaD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000381	0.00237	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—NAT2—urinary bladder cancer	0.000377	0.00234	CbGpPWpGaD
Fenofibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000376	0.00234	CbGpPWpGaD
Fenofibrate—CYP2C8—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000371	0.00231	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000369	0.00229	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000369	0.00229	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000364	0.00226	CbGpPWpGaD
Fenofibrate—PPARA—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000363	0.00226	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTO2—urinary bladder cancer	0.000362	0.00225	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NAT1—urinary bladder cancer	0.000362	0.00225	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000357	0.00222	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—CDKN1A—urinary bladder cancer	0.000354	0.0022	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000339	0.00211	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000337	0.0021	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000333	0.00207	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—UGT2B7—urinary bladder cancer	0.000332	0.00206	CbGpPWpGaD
Fenofibrate—PPARA—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000308	0.00192	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000307	0.00191	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000304	0.00189	CbGpPWpGaD
Fenofibrate—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000302	0.00188	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000301	0.00187	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.0003	0.00186	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CYP4B1—urinary bladder cancer	0.000299	0.00186	CbGpPWpGaD
Fenofibrate—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.000292	0.00182	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—SLC19A1—urinary bladder cancer	0.000282	0.00175	CbGpPWpGaD
Fenofibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000282	0.00175	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PRSS3—urinary bladder cancer	0.000275	0.00171	CbGpPWpGaD
Fenofibrate—PPARA—Adipogenesis—TNF—urinary bladder cancer	0.000273	0.0017	CbGpPWpGaD
Fenofibrate—Sweating—Epirubicin—urinary bladder cancer	0.000262	0.000628	CcSEcCtD
Fenofibrate—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000262	0.000628	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000262	0.00163	CbGpPWpGaD
Fenofibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000262	0.00163	CbGpPWpGaD
Fenofibrate—Asthenia—Gemcitabine—urinary bladder cancer	0.000262	0.000626	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—urinary bladder cancer	0.000261	0.000623	CcSEcCtD
Fenofibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000259	0.00161	CbGpPWpGaD
Fenofibrate—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000259	0.00062	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000259	0.000619	CcSEcCtD
Fenofibrate—Weight increased—Doxorubicin—urinary bladder cancer	0.000258	0.000618	CcSEcCtD
Fenofibrate—Pruritus—Gemcitabine—urinary bladder cancer	0.000258	0.000617	CcSEcCtD
Fenofibrate—Nausea—Thiotepa—urinary bladder cancer	0.000257	0.000616	CcSEcCtD
Fenofibrate—Weight decreased—Doxorubicin—urinary bladder cancer	0.000257	0.000615	CcSEcCtD
Fenofibrate—Sinusitis—Epirubicin—urinary bladder cancer	0.000257	0.000614	CcSEcCtD
Fenofibrate—Feeling abnormal—Etoposide—urinary bladder cancer	0.000257	0.000614	CcSEcCtD
Fenofibrate—Pneumonia—Doxorubicin—urinary bladder cancer	0.000255	0.000609	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000255	0.000609	CcSEcCtD
Fenofibrate—Pruritus—Fluorouracil—urinary bladder cancer	0.000254	0.000607	CcSEcCtD
Fenofibrate—Infestation—Doxorubicin—urinary bladder cancer	0.000253	0.000606	CcSEcCtD
Fenofibrate—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000253	0.000606	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—urinary bladder cancer	0.000253	0.000605	CcSEcCtD
Fenofibrate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00025	0.000599	CcSEcCtD
Fenofibrate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000249	0.000597	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000249	0.00155	CbGpPWpGaD
Fenofibrate—Renal failure—Doxorubicin—urinary bladder cancer	0.000249	0.000596	CcSEcCtD
Fenofibrate—Urticaria—Etoposide—urinary bladder cancer	0.000247	0.000592	CcSEcCtD
Fenofibrate—Jaundice—Doxorubicin—urinary bladder cancer	0.000247	0.000591	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—NCOR1—urinary bladder cancer	0.000247	0.00153	CbGpPWpGaD
Fenofibrate—Rhinitis—Epirubicin—urinary bladder cancer	0.000246	0.000589	CcSEcCtD
Fenofibrate—Body temperature increased—Etoposide—urinary bladder cancer	0.000246	0.000589	CcSEcCtD
Fenofibrate—Abdominal pain—Etoposide—urinary bladder cancer	0.000246	0.000589	CcSEcCtD
Fenofibrate—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000246	0.000589	CcSEcCtD
Fenofibrate—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000246	0.000589	CcSEcCtD
Fenofibrate—Hepatitis—Epirubicin—urinary bladder cancer	0.000246	0.000588	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—urinary bladder cancer	0.000245	0.000587	CcSEcCtD
Fenofibrate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000245	0.000587	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000245	0.00152	CbGpPWpGaD
Fenofibrate—Asthenia—Cisplatin—urinary bladder cancer	0.000244	0.000583	CcSEcCtD
Fenofibrate—Pharyngitis—Epirubicin—urinary bladder cancer	0.000244	0.000583	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000244	0.000583	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—urinary bladder cancer	0.000243	0.000581	CcSEcCtD
Fenofibrate—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000242	0.000579	CcSEcCtD
Fenofibrate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000241	0.000578	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000239	0.000573	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—urinary bladder cancer	0.000238	0.00057	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000238	0.00148	CbGpPWpGaD
Fenofibrate—Sinusitis—Doxorubicin—urinary bladder cancer	0.000238	0.000568	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—EP300—urinary bladder cancer	0.000237	0.00148	CbGpPWpGaD
Fenofibrate—Dizziness—Fluorouracil—urinary bladder cancer	0.000237	0.000567	CcSEcCtD
Fenofibrate—Visual impairment—Epirubicin—urinary bladder cancer	0.000237	0.000566	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000237	0.000566	CcSEcCtD
Fenofibrate—Diarrhoea—Cisplatin—urinary bladder cancer	0.000233	0.000556	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—urinary bladder cancer	0.000232	0.000555	CcSEcCtD
Fenofibrate—Vomiting—Gemcitabine—urinary bladder cancer	0.000232	0.000555	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—urinary bladder cancer	0.00023	0.00055	CcSEcCtD
Fenofibrate—Rash—Gemcitabine—urinary bladder cancer	0.00023	0.00055	CcSEcCtD
Fenofibrate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00023	0.00055	CcSEcCtD
Fenofibrate—Eye disorder—Epirubicin—urinary bladder cancer	0.00023	0.000549	CcSEcCtD
Fenofibrate—Hypersensitivity—Etoposide—urinary bladder cancer	0.000229	0.000549	CcSEcCtD
Fenofibrate—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000229	0.00143	CbGpPWpGaD
Fenofibrate—Malnutrition—Methotrexate—urinary bladder cancer	0.000229	0.000547	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—urinary bladder cancer	0.000229	0.000547	CcSEcCtD
Fenofibrate—Headache—Gemcitabine—urinary bladder cancer	0.000228	0.000547	CcSEcCtD
Fenofibrate—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000228	0.000546	CcSEcCtD
Fenofibrate—Vomiting—Fluorouracil—urinary bladder cancer	0.000228	0.000545	CcSEcCtD
Fenofibrate—Rhinitis—Doxorubicin—urinary bladder cancer	0.000228	0.000545	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—urinary bladder cancer	0.000227	0.000544	CcSEcCtD
Fenofibrate—Rash—Fluorouracil—urinary bladder cancer	0.000226	0.000541	CcSEcCtD
Fenofibrate—Dermatitis—Fluorouracil—urinary bladder cancer	0.000226	0.00054	CcSEcCtD
Fenofibrate—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000226	0.00054	CcSEcCtD
Fenofibrate—Headache—Fluorouracil—urinary bladder cancer	0.000225	0.000537	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000224	0.000536	CcSEcCtD
Fenofibrate—Asthenia—Etoposide—urinary bladder cancer	0.000223	0.000535	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000223	0.000534	CcSEcCtD
Fenofibrate—Angiopathy—Epirubicin—urinary bladder cancer	0.000223	0.000533	CcSEcCtD
Fenofibrate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000221	0.00053	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—urinary bladder cancer	0.000221	0.000529	CcSEcCtD
Fenofibrate—Pruritus—Etoposide—urinary bladder cancer	0.00022	0.000527	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00022	0.00137	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—TYMP—urinary bladder cancer	0.00022	0.00137	CbGpPWpGaD
Fenofibrate—Arrhythmia—Epirubicin—urinary bladder cancer	0.000219	0.000525	CcSEcCtD
Fenofibrate—Visual impairment—Doxorubicin—urinary bladder cancer	0.000219	0.000524	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000217	0.00135	CbGpPWpGaD
Fenofibrate—Alopecia—Epirubicin—urinary bladder cancer	0.000217	0.000519	CcSEcCtD
Fenofibrate—Nausea—Gemcitabine—urinary bladder cancer	0.000217	0.000518	CcSEcCtD
Fenofibrate—Vomiting—Cisplatin—urinary bladder cancer	0.000216	0.000517	CcSEcCtD
Fenofibrate—Mental disorder—Epirubicin—urinary bladder cancer	0.000215	0.000515	CcSEcCtD
Fenofibrate—Rash—Cisplatin—urinary bladder cancer	0.000214	0.000513	CcSEcCtD
Fenofibrate—Dermatitis—Cisplatin—urinary bladder cancer	0.000214	0.000512	CcSEcCtD
Fenofibrate—Malnutrition—Epirubicin—urinary bladder cancer	0.000214	0.000512	CcSEcCtD
Fenofibrate—Erythema—Epirubicin—urinary bladder cancer	0.000214	0.000512	CcSEcCtD
Fenofibrate—Diarrhoea—Etoposide—urinary bladder cancer	0.000213	0.00051	CcSEcCtD
Fenofibrate—Nausea—Fluorouracil—urinary bladder cancer	0.000213	0.00051	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—urinary bladder cancer	0.000212	0.000508	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000212	0.000507	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—urinary bladder cancer	0.000211	0.000505	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000211	0.000505	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000211	0.00131	CbGpPWpGaD
Fenofibrate—Flatulence—Epirubicin—urinary bladder cancer	0.000211	0.000504	CcSEcCtD
Fenofibrate—Tension—Epirubicin—urinary bladder cancer	0.00021	0.000502	CcSEcCtD
Fenofibrate—Nervousness—Epirubicin—urinary bladder cancer	0.000208	0.000497	CcSEcCtD
Fenofibrate—Back pain—Epirubicin—urinary bladder cancer	0.000207	0.000495	CcSEcCtD
Fenofibrate—Angiopathy—Doxorubicin—urinary bladder cancer	0.000206	0.000493	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—urinary bladder cancer	0.000206	0.000493	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—urinary bladder cancer	0.000206	0.000493	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000206	0.00128	CbGpPWpGaD
Fenofibrate—Muscle spasms—Epirubicin—urinary bladder cancer	0.000206	0.000492	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—urinary bladder cancer	0.000205	0.000491	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000205	0.00049	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—urinary bladder cancer	0.000205	0.000489	CcSEcCtD
Fenofibrate—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000203	0.000486	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	0.000202	0.00126	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000202	0.00126	CbGpPWpGaD
Fenofibrate—Nausea—Cisplatin—urinary bladder cancer	0.000202	0.000483	CcSEcCtD
Fenofibrate—Alopecia—Doxorubicin—urinary bladder cancer	0.000201	0.000481	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.0002	0.00124	CbGpPWpGaD
Fenofibrate—Cough—Methotrexate—urinary bladder cancer	0.000199	0.000477	CcSEcCtD
Fenofibrate—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000199	0.00124	CbGpPWpGaD
Fenofibrate—Mental disorder—Doxorubicin—urinary bladder cancer	0.000199	0.000476	CcSEcCtD
Fenofibrate—PPARA—Metabolism—NAT2—urinary bladder cancer	0.000199	0.00124	CbGpPWpGaD
Fenofibrate—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000198	0.000475	CcSEcCtD
Fenofibrate—Vomiting—Etoposide—urinary bladder cancer	0.000198	0.000474	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—urinary bladder cancer	0.000198	0.000473	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—urinary bladder cancer	0.000198	0.000473	CcSEcCtD
Fenofibrate—Anaemia—Epirubicin—urinary bladder cancer	0.000198	0.000473	CcSEcCtD
Fenofibrate—Rash—Etoposide—urinary bladder cancer	0.000196	0.00047	CcSEcCtD
Fenofibrate—Dermatitis—Etoposide—urinary bladder cancer	0.000196	0.000469	CcSEcCtD
Fenofibrate—Headache—Etoposide—urinary bladder cancer	0.000195	0.000467	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—urinary bladder cancer	0.000195	0.000467	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—urinary bladder cancer	0.000195	0.000465	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—urinary bladder cancer	0.000195	0.000465	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—urinary bladder cancer	0.000195	0.000465	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—CDK4—urinary bladder cancer	0.000195	0.00121	CbGpPWpGaD
Fenofibrate—Tension—Doxorubicin—urinary bladder cancer	0.000194	0.000465	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000193	0.000462	CcSEcCtD
Fenofibrate—Malaise—Epirubicin—urinary bladder cancer	0.000193	0.000461	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—urinary bladder cancer	0.000192	0.00046	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—urinary bladder cancer	0.000192	0.00046	CcSEcCtD
Fenofibrate—Vertigo—Epirubicin—urinary bladder cancer	0.000192	0.00046	CcSEcCtD
Fenofibrate—Leukopenia—Epirubicin—urinary bladder cancer	0.000191	0.000458	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—urinary bladder cancer	0.000191	0.000458	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00019	0.000455	CcSEcCtD
Fenofibrate—Palpitations—Epirubicin—urinary bladder cancer	0.000189	0.000452	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000188	0.00117	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—SMC1A—urinary bladder cancer	0.000187	0.00117	CbGpPWpGaD
Fenofibrate—Cough—Epirubicin—urinary bladder cancer	0.000187	0.000447	CcSEcCtD
Fenofibrate—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	0.000186	0.00116	CbGpPWpGaD
Fenofibrate—Infection—Methotrexate—urinary bladder cancer	0.000185	0.000443	CcSEcCtD
Fenofibrate—Nausea—Etoposide—urinary bladder cancer	0.000185	0.000443	CcSEcCtD
Fenofibrate—Hypertension—Epirubicin—urinary bladder cancer	0.000185	0.000442	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000184	0.000439	CcSEcCtD
Fenofibrate—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000183	0.00114	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000183	0.000438	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—urinary bladder cancer	0.000183	0.000438	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000183	0.000437	CcSEcCtD
Fenofibrate—Arthralgia—Epirubicin—urinary bladder cancer	0.000182	0.000436	CcSEcCtD
Fenofibrate—Chest pain—Epirubicin—urinary bladder cancer	0.000182	0.000436	CcSEcCtD
Fenofibrate—Myalgia—Epirubicin—urinary bladder cancer	0.000182	0.000436	CcSEcCtD
Fenofibrate—Anxiety—Epirubicin—urinary bladder cancer	0.000181	0.000434	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—urinary bladder cancer	0.000181	0.000433	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000181	0.000433	CcSEcCtD
Fenofibrate—PPARA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.00018	0.00112	CbGpPWpGaD
Fenofibrate—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00018	0.000431	CcSEcCtD
Fenofibrate—Discomfort—Epirubicin—urinary bladder cancer	0.00018	0.00043	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—urinary bladder cancer	0.000178	0.000427	CcSEcCtD
Fenofibrate—Dry mouth—Epirubicin—urinary bladder cancer	0.000178	0.000426	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—urinary bladder cancer	0.000178	0.000425	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—urinary bladder cancer	0.000178	0.000425	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—urinary bladder cancer	0.000177	0.000424	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000177	0.0011	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—PPARG—urinary bladder cancer	0.000177	0.0011	CbGpPWpGaD
Fenofibrate—Palpitations—Doxorubicin—urinary bladder cancer	0.000175	0.000418	CcSEcCtD
Fenofibrate—Oedema—Epirubicin—urinary bladder cancer	0.000175	0.000418	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—urinary bladder cancer	0.000174	0.000417	CcSEcCtD
Fenofibrate—Infection—Epirubicin—urinary bladder cancer	0.000173	0.000415	CcSEcCtD
Fenofibrate—Cough—Doxorubicin—urinary bladder cancer	0.000173	0.000413	CcSEcCtD
Fenofibrate—PPARA—Metabolism—RRM2—urinary bladder cancer	0.000171	0.00107	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000171	0.00041	CcSEcCtD
Fenofibrate—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000171	0.000409	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—urinary bladder cancer	0.000171	0.000409	CcSEcCtD
Fenofibrate—Tachycardia—Epirubicin—urinary bladder cancer	0.00017	0.000408	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00017	0.000407	CcSEcCtD
Fenofibrate—PPARA—Circadian rythm related genes—TP53—urinary bladder cancer	0.00017	0.00106	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—CREBBP—urinary bladder cancer	0.00017	0.00106	CbGpPWpGaD
Fenofibrate—Skin disorder—Epirubicin—urinary bladder cancer	0.00017	0.000406	CcSEcCtD
Fenofibrate—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000169	0.000404	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—urinary bladder cancer	0.000169	0.000404	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—urinary bladder cancer	0.000168	0.000403	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—urinary bladder cancer	0.000168	0.000403	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—urinary bladder cancer	0.000168	0.000403	CcSEcCtD
Fenofibrate—Anxiety—Doxorubicin—urinary bladder cancer	0.000168	0.000402	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000167	0.000401	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000167	0.0004	CcSEcCtD
Fenofibrate—Discomfort—Doxorubicin—urinary bladder cancer	0.000166	0.000398	CcSEcCtD
Fenofibrate—Anorexia—Epirubicin—urinary bladder cancer	0.000166	0.000398	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—urinary bladder cancer	0.000166	0.000398	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—urinary bladder cancer	0.000166	0.000397	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—urinary bladder cancer	0.000165	0.000394	CcSEcCtD
Fenofibrate—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000165	0.00102	CbGpPWpGaD
Fenofibrate—Dyspepsia—Methotrexate—urinary bladder cancer	0.000164	0.000393	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—ESR2—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Fenofibrate—Hypotension—Epirubicin—urinary bladder cancer	0.000163	0.00039	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000162	0.00101	CbGpPWpGaD
Fenofibrate—Decreased appetite—Methotrexate—urinary bladder cancer	0.000162	0.000388	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000162	0.00101	CbGpPWpGaD
Fenofibrate—Oedema—Doxorubicin—urinary bladder cancer	0.000162	0.000386	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000161	0.000385	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—urinary bladder cancer	0.000161	0.000385	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—urinary bladder cancer	0.00016	0.000384	CcSEcCtD
Fenofibrate—Pain—Methotrexate—urinary bladder cancer	0.000159	0.000382	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000159	0.00038	CcSEcCtD
Fenofibrate—PPARA—Metabolism—HPGDS—urinary bladder cancer	0.000159	0.000988	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ENO2—urinary bladder cancer	0.000159	0.000988	CbGpPWpGaD
Fenofibrate—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000158	0.000379	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000158	0.000378	CcSEcCtD
Fenofibrate—Insomnia—Epirubicin—urinary bladder cancer	0.000158	0.000378	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000158	0.000982	CbGpPWpGaD
Fenofibrate—Tachycardia—Doxorubicin—urinary bladder cancer	0.000158	0.000377	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—urinary bladder cancer	0.000157	0.000375	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000157	0.000975	CbGpPWpGaD
Fenofibrate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000157	0.000375	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000156	0.000374	CcSEcCtD
Fenofibrate—Dyspnoea—Epirubicin—urinary bladder cancer	0.000156	0.000372	CcSEcCtD
Fenofibrate—Somnolence—Epirubicin—urinary bladder cancer	0.000155	0.000371	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GSTT1—urinary bladder cancer	0.000154	0.000958	CbGpPWpGaD
Fenofibrate—Anorexia—Doxorubicin—urinary bladder cancer	0.000154	0.000368	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000154	0.000368	CcSEcCtD
Fenofibrate—Dyspepsia—Epirubicin—urinary bladder cancer	0.000154	0.000368	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—RHOA—urinary bladder cancer	0.000154	0.000955	CbGpPWpGaD
Fenofibrate—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000153	0.000365	CcSEcCtD
Fenofibrate—Decreased appetite—Epirubicin—urinary bladder cancer	0.000152	0.000363	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000152	0.000943	CbGpPWpGaD
Fenofibrate—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000151	0.000942	CbGpPWpGaD
Fenofibrate—Hypotension—Doxorubicin—urinary bladder cancer	0.000151	0.000361	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000151	0.000361	CcSEcCtD
Fenofibrate—Fatigue—Epirubicin—urinary bladder cancer	0.00015	0.00036	CcSEcCtD
Fenofibrate—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000149	0.000929	CbGpPWpGaD
Fenofibrate—Constipation—Epirubicin—urinary bladder cancer	0.000149	0.000357	CcSEcCtD
Fenofibrate—Pain—Epirubicin—urinary bladder cancer	0.000149	0.000357	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—urinary bladder cancer	0.000148	0.000354	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000147	0.000353	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—urinary bladder cancer	0.000147	0.000353	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000147	0.000352	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—urinary bladder cancer	0.000146	0.000349	CcSEcCtD
Fenofibrate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000145	0.000347	CcSEcCtD
Fenofibrate—PPARA—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000144	0.000897	CbGpPWpGaD
Fenofibrate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000144	0.000344	CcSEcCtD
Fenofibrate—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000144	0.000344	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—urinary bladder cancer	0.000144	0.000344	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000143	0.000341	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—ERBB2—urinary bladder cancer	0.000142	0.000884	CbGpPWpGaD
Fenofibrate—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000142	0.00034	CcSEcCtD
Fenofibrate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00014	0.000336	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000139	0.000334	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—urinary bladder cancer	0.000139	0.000333	CcSEcCtD
Fenofibrate—Urticaria—Epirubicin—urinary bladder cancer	0.000139	0.000332	CcSEcCtD
Fenofibrate—Pain—Doxorubicin—urinary bladder cancer	0.000138	0.00033	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—urinary bladder cancer	0.000138	0.00033	CcSEcCtD
Fenofibrate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000138	0.00033	CcSEcCtD
Fenofibrate—Abdominal pain—Epirubicin—urinary bladder cancer	0.000138	0.00033	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000137	0.000329	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—urinary bladder cancer	0.000134	0.00032	CcSEcCtD
Fenofibrate—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000133	0.000318	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000132	0.000316	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—urinary bladder cancer	0.000132	0.000316	CcSEcCtD
Fenofibrate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000129	0.000308	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—urinary bladder cancer	0.000128	0.000307	CcSEcCtD
Fenofibrate—PPARA—Metabolism—NQO1—urinary bladder cancer	0.000128	0.000796	CbGpPWpGaD
Fenofibrate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000128	0.000305	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000128	0.000305	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000128	0.000305	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—NCOR1—urinary bladder cancer	0.000126	0.000785	CbGpPWpGaD
Fenofibrate—Asthenia—Epirubicin—urinary bladder cancer	0.000125	0.0003	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000124	0.000772	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	0.000124	0.000771	CbGpPWpGaD
Fenofibrate—Pruritus—Epirubicin—urinary bladder cancer	0.000123	0.000295	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—urinary bladder cancer	0.000123	0.000295	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—MMP9—urinary bladder cancer	0.000122	0.000759	CbGpPWpGaD
Fenofibrate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000119	0.000286	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000119	0.000285	CcSEcCtD
Fenofibrate—PPARA—Gene Expression—ERCC2—urinary bladder cancer	0.000119	0.000738	CbGpPWpGaD
Fenofibrate—Vomiting—Methotrexate—urinary bladder cancer	0.000119	0.000284	CcSEcCtD
Fenofibrate—Rash—Methotrexate—urinary bladder cancer	0.000118	0.000281	CcSEcCtD
Fenofibrate—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	0.000118	0.000731	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NAT1—urinary bladder cancer	0.000118	0.000731	CbGpPWpGaD
Fenofibrate—Dermatitis—Methotrexate—urinary bladder cancer	0.000117	0.000281	CcSEcCtD
Fenofibrate—Headache—Methotrexate—urinary bladder cancer	0.000117	0.00028	CcSEcCtD
Fenofibrate—Asthenia—Doxorubicin—urinary bladder cancer	0.000116	0.000277	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—EP300—urinary bladder cancer	0.000116	0.000719	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000116	0.000719	CbGpPWpGaD
Fenofibrate—Dizziness—Epirubicin—urinary bladder cancer	0.000115	0.000276	CcSEcCtD
Fenofibrate—Pruritus—Doxorubicin—urinary bladder cancer	0.000114	0.000273	CcSEcCtD
Fenofibrate—PPARA—Developmental Biology—SRC—urinary bladder cancer	0.000112	0.000699	CbGpPWpGaD
Fenofibrate—Vomiting—Epirubicin—urinary bladder cancer	0.000111	0.000266	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—urinary bladder cancer	0.000111	0.000265	CcSEcCtD
Fenofibrate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00011	0.000264	CcSEcCtD
Fenofibrate—Rash—Epirubicin—urinary bladder cancer	0.00011	0.000263	CcSEcCtD
Fenofibrate—Dermatitis—Epirubicin—urinary bladder cancer	0.00011	0.000263	CcSEcCtD
Fenofibrate—Headache—Epirubicin—urinary bladder cancer	0.000109	0.000262	CcSEcCtD
Fenofibrate—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000109	0.000676	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000108	0.000674	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	0.000108	0.000669	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000107	0.000667	CbGpPWpGaD
Fenofibrate—PPARA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000107	0.000666	CbGpPWpGaD
Fenofibrate—Dizziness—Doxorubicin—urinary bladder cancer	0.000107	0.000256	CcSEcCtD
Fenofibrate—PPARA—Metabolism—GSTP1—urinary bladder cancer	0.000107	0.000664	CbGpPWpGaD
Fenofibrate—Nausea—Epirubicin—urinary bladder cancer	0.000104	0.000248	CcSEcCtD
Fenofibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000103	0.000642	CbGpPWpGaD
Fenofibrate—Vomiting—Doxorubicin—urinary bladder cancer	0.000103	0.000246	CcSEcCtD
Fenofibrate—Rash—Doxorubicin—urinary bladder cancer	0.000102	0.000244	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000102	0.000243	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—urinary bladder cancer	0.000101	0.000242	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000101	0.000628	CbGpPWpGaD
Fenofibrate—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.98e-05	0.000621	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—TYMS—urinary bladder cancer	9.92e-05	0.000617	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—ESR1—urinary bladder cancer	9.91e-05	0.000616	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—EGFR—urinary bladder cancer	9.86e-05	0.000613	CbGpPWpGaD
Fenofibrate—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.85e-05	0.000612	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—NCOR1—urinary bladder cancer	9.81e-05	0.00061	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GSTM1—urinary bladder cancer	9.81e-05	0.00061	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	9.68e-05	0.000602	CbGpPWpGaD
Fenofibrate—Nausea—Doxorubicin—urinary bladder cancer	9.59e-05	0.00023	CcSEcCtD
Fenofibrate—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	9.57e-05	0.000595	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NAT1—urinary bladder cancer	9.57e-05	0.000595	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.41e-05	0.000585	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—GPX1—urinary bladder cancer	9.39e-05	0.000584	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—TNF—urinary bladder cancer	9.39e-05	0.000584	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—KRAS—urinary bladder cancer	9.31e-05	0.000579	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—ERCC2—urinary bladder cancer	9.22e-05	0.000574	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	9.14e-05	0.000569	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—PPARG—urinary bladder cancer	9.04e-05	0.000562	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	8.91e-05	0.000554	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	8.75e-05	0.000544	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—CREBBP—urinary bladder cancer	8.69e-05	0.00054	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—MTHFR—urinary bladder cancer	8.67e-05	0.000539	CbGpPWpGaD
Fenofibrate—PPARA—Developmental Biology—HRAS—urinary bladder cancer	7.91e-05	0.000492	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	7.88e-05	0.00049	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	7.44e-05	0.000463	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	7.25e-05	0.000451	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.14e-05	0.000444	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TYMP—urinary bladder cancer	7.12e-05	0.000443	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PPARG—urinary bladder cancer	7.03e-05	0.000437	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.84e-05	0.000425	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—CREBBP—urinary bladder cancer	6.75e-05	0.00042	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.66e-05	0.000414	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NAT2—urinary bladder cancer	6.44e-05	0.000401	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.31e-05	0.000392	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.31e-05	0.000392	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.81e-05	0.000362	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TYMP—urinary bladder cancer	5.8e-05	0.000361	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.77e-05	0.000359	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.57e-05	0.000346	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.56e-05	0.000346	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTGS2—urinary bladder cancer	5.53e-05	0.000344	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.24e-05	0.000326	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.2e-05	0.000323	CbGpPWpGaD
Fenofibrate—PPARA—Gene Expression—MYC—urinary bladder cancer	5.15e-05	0.000321	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	5.15e-05	0.00032	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ENO2—urinary bladder cancer	5.15e-05	0.00032	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.12e-05	0.000318	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	4.99e-05	0.000311	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.92e-05	0.000306	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.91e-05	0.000305	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—PTEN—urinary bladder cancer	4.82e-05	0.0003	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.78e-05	0.000297	CbGpPWpGaD
Fenofibrate—PPARA—Metabolism—EP300—urinary bladder cancer	4.6e-05	0.000286	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.52e-05	0.000281	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.19e-05	0.000261	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.19e-05	0.000261	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.17e-05	0.000259	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.15e-05	0.000258	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.06e-05	0.000253	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.03e-05	0.00025	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4e-05	0.000249	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.82e-05	0.000238	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.51e-05	0.000218	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.46e-05	0.000215	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.46e-05	0.000215	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.38e-05	0.00021	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.35e-05	0.000208	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.28e-05	0.000204	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.22e-05	0.0002	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.18e-05	0.000198	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.18e-05	0.000198	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.05e-05	0.000189	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.99e-05	0.000186	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.98e-05	0.000186	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.86e-05	0.000178	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.82e-05	0.000175	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.81e-05	0.000175	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.76e-05	0.000172	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.76e-05	0.000172	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.73e-05	0.00017	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.68e-05	0.000167	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.62e-05	0.000163	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.59e-05	0.000161	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.59e-05	0.000161	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.48e-05	0.000154	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.43e-05	0.000151	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.29e-05	0.000142	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.28e-05	0.000142	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.23e-05	0.000139	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.19e-05	0.000136	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.86e-05	0.000116	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.86e-05	0.000115	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.79e-05	0.000112	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.78e-05	0.000111	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.73e-05	0.000107	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.71e-05	0.000106	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.71e-05	0.000106	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.64e-05	0.000102	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.61e-05	9.99e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.56e-05	9.73e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.51e-05	9.39e-05	CbGpPWpGaD
Fenofibrate—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.49e-05	9.28e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.46e-05	9.08e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.27e-05	7.92e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.22e-05	7.61e-05	CbGpPWpGaD
Fenofibrate—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.21e-05	7.55e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.18e-05	7.31e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.63e-06	5.99e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.39e-06	5.22e-05	CbGpPWpGaD
Fenofibrate—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.01e-06	4.98e-05	CbGpPWpGaD
